[Damage to skeletal muscles by intramuscular administration of anti-inflammatory agents of the pyrazolidine type].
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D004338:Drug Combinations / Q000009:adverse effects; D007273:Injections, Intramuscular / Q000009:adverse effects; D008297:Male; D009132:Muscles / Q000473:pathology*; D009336:Necrosis; D010653:Phenylbutazone / Q000009:adverse effects* / Q000031:analogs & derivatives*; D011437:Propylamines / Q000009:adverse effects*; D011817:Rabbits; D051381:Rats; D011919:Rats, Inbred Strains
D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D011437:Propylamines; C100280:kebuzone; C003618:isopryn, phenylbutazone drug combination; D010653:Phenylbutazone
Poskození kosterního svalu intramuskulárním podáním protizánĕtlivých látek pyrazolidinového typu.